MedRx Co., Ltd (TYO:4586)
Japan · Delayed Price · Currency is JPY 110.00
-15.00 (-12.00%)
Mar 6, 2026, 11:30 AM JST
MedRx Market Cap
MedRx has a market cap or net worth of 7.42 billion as of March 5, 2026. Its market cap has increased by 95.30% in one year.
Market Cap
7.42B
Enterprise Value
5.67B
Revenue
128.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
110.00
Market Cap Chart
Since February 13, 2013, MedRx's market cap has decreased from 11.76B to 7.42B, a decrease of -36.90%. That is a compound annual growth rate of -3.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 5.64B | -12.04% |
| Dec 30, 2025 | 6.41B | 65.15% |
| Dec 30, 2024 | 3.88B | -32.98% |
| Dec 29, 2023 | 5.79B | 117.37% |
| Dec 30, 2022 | 2.67B | -15.34% |
| Dec 30, 2021 | 3.15B | -20.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 20.70B |
| Pharma Foods International | 16.77B |
| Taiko Pharmaceutical | 14.82B |
| Wakamoto Pharmaceutical | 11.76B |
| Morishita Jintan | 9.50B |
| Solasia Pharma K.K. | 8.89B |
| SymBio Pharmaceuticals | 8.38B |
| WDB coco | 6.52B |